Crohn’s disease, a chronic inflammatory bowel disease, can have a huge impact on people’s lives. The condition can be diagnosed at any age, but most commonly before the age of 30, and affects men and women equally. It may initially be confused with irritable bowel syndrome (IBS), which is why it’s so important that ongoing or severe digestive symptoms are always checked out by a GP.
Dr Rachel Ainley, head of research and evidence at Crohn’s & Colitis UK, says that community pharmacies have a vital role to play in identifying the symptoms. “This can make the difference between people getting treatment early that sets them on a path to remission, or seeing their health deteriorate into severe illness,” she says.
“We are about to launch a podcast for community pharmacists to raise awareness of these often-invisible conditions, helping them spot the symptoms to enable earlier diagnosis, and provide better support for those living with them.”
Cases on the rise
New results from a study commissioned by Crohn’s & Colitis UK have shown that the number of people living with Crohn’s disease or ulcerative colitis (as well as unclassified IBD) in the UK has been vastly underestimated. The research, which was carried out at the University of Nottingham and funded by Crohn’s & Colitis UK and Coeliac UK, shows that there are over half a million people (one in every 123) in the country living with IBD, nearly double that of the 300,000 previously estimated. This rises to one in every 67 people over the age of 70.
“Outdated figures mean the scale of the issue has been overlooked for too long,” says Sarah Sleet, CEO of Crohn’s & Colitis UK. “Lifetime costs for the NHS for treating these conditions are comparable to heart disease and cancer.
“The conditions can have a profound impact on a person’s life and patients need expert care from doctors, specialist nurses, dietitians, pharmacists and psychologists. It’s crucial that the NHS recognises the scale of the growing numbers with Crohn’s and colitis and does more to prevent lives being blighted for decades by these debilitating illnesses.”
What is Crohn’s disease?
In Crohn’s disease, the immune system attacks the digestive system which is called an autoimmune reaction. This is most common in the small bowel and colon, but can occur anywhere in the digestive system from the mouth to the anus. Areas of inflammation are often patchy, with sections of healthy gut between them. The condition is usually diagnosed with an endoscopy and other tests.
The cause of Crohn’s disease is still unknown, but it’s thought to be a mixture of genetics, bacteria levels in the gut and environment factors. Crohn’s tends to run in families; if one parent has Crohn’s, the risk of their child developing Crohn’s or colitis is generally thought to be between five and 10 per cent. The risk of Crohn’s disease may be higher in smokers and after a gastroenteritis infection.
People with Crohn’s have fewer varieties of helpful bacteria in their gut than people without Crohn’s, and some helpful bacteria are missing completely. New evidence suggests that other bacteria in the gut may produce proteins that cause inflammation and lead to the development of Crohn’s.